Patients with cancer are presumed to be at increased risk from COVID-19 infection–related
fatality due to underlying malignancy, treatment-related immunosuppression, or increased …

Two recent Lancet and Lancet Oncology papers report that cancer patients with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have higher mortality …

Introduction Since the early SARS-CoV-2 pandemic, cancer patients have been assumed to
be at higher risk for severe COVID-19. Here, we present an analysis of cancer patients from …

Patients with cancer have been disproportionately affected by the COVID-19 pandemic. This
effect has included the adverse outcomes in patients with cancer who develop COVID-19 …

Importance Patients with specific cancers may be at higher risk than those without cancer for
coronavirus disease 2019 (COVID-19) and its severe outcomes. At present, limited data are …

Importance Large cohorts of patients with active cancers and COVID-19 infection are
needed to provide evidence of the association of recent cancer treatment and cancer type …

The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying
diagnoses and treatment and halting clinical trials. In response, healthcare systems are …

Recently, anoutbreakofthehighlyinfectiousnovelcoron… (COVID-19) hassweptWuhan,
China, with 80 303 confirmed diagnosed cases in China as of March 3, 2020. 1 Considering …

Abstract Purpose of Review The outbreak of the novel coronavirus disease 2019 (COVID-
19) has emerged to be the biggest global health threat worldwide, which has now infected …

Background Despite high contagiousness and rapid spread, severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has led to heterogeneous outcomes across affected …